Mutual fund unlocked: What is offer document and KIM?
Mutual fund unlocked: What is offer document and KIM?

Mutual fund unlocked: What is offer document and KIM?

Nikhil Desai Article rating: 3.4

We often hear and read that, “Mutual fund investments are subject to market risk. Please read the scheme related documents carefully.” in multiple languages. But has anyone read it? Do we know what is an offer document and the key information memorandum (KIM)? What does it contain?

Q4FY18 Results: Muthoot Finance witnesses subdued revenue
Q4FY18 Results: Muthoot Finance witnesses subdued revenue

Q4FY18 Results: Muthoot Finance witnesses subdued revenue

Rohan Takalkar Article rating: No rating

Muthoot Financial Services reported weak numbers for the quarter with subdued revenue and modest loan assets growth over the FY18

Muthoot Financial Services reported weak numbers for the quarter with subdued revenue and modest loan assets growth over the FY18.

Muthoot Financial Services reported weak numbers for the quarter with subdued revenue and modest loan assets growth over the FY18.

Muthoot Financial Services reported weak numbers for the quarter with subdued revenue and modest loan assets growth over the FY18.


Mutual fund unlocked: Credit opportunities fund
Mutual fund unlocked: Credit opportunities fund

Mutual fund unlocked: Credit opportunities fund

Nikhil Desai Article rating: 4.5

Investors usually spread investments across the asset classes to reduce risk. Debt funds are commonly used to cushion market volatility. Credit opportunity fund is a type of debt fund which although is not so popular among the investors is a good investment option.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on May 16, 2018 opened gap down. BSE Sensex is trading at 35,515.54, down by 28.40 points and the Nifty is trading at 10,777.05, down by 24.80 points. 

Vivimed acquires Hungarian firm Soneas
Vivimed acquires Hungarian firm Soneas

Vivimed acquires Hungarian firm Soneas

Gayathri Udyawar Article rating: 5.0

Vivimed Labs Limited, a pharmaceuticals and specialty chemicals company, has agreed to acquire Soneas through its API arm UQUIFA.

RSS
First33423343334433453347334933503351Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR